Synthesis and anti-HIV activity of l-2′,3′-Dideoxy-4′-selenonucleosides (l-4′-Se-ddNs)


Based on the potent anti-HIV activity of l-2′,3′-dideoxycytidine (l-ddC), l-2′,3′-dideoxy-4′-selenonucleosides (l-4′-Se-ddNs) have been synthesized from natural chiral template, l-glutamic acid, using Pummerer-type condensation as a key step. All synthesized compounds were assayed for anti-HIV-1 activity, but none of them did show any significant antiviral activity up to 100 μM, probably due to conformational differences between l-ddC and l-4′-Se-ddC, induced by the bulky selenium atom, which might play an important role in phosphorylation by cellular kinase.

This is a preview of subscription content, access via your institution.

Fig. 1
Scheme 1
Scheme 2
Scheme 3
Fig. 2


  1. Birnbaum GI (1988) Unusual structural features of 2′,3′-dideoxycytidine, an inhibitor of the HIV (AIDS) virus. Biochem Biophys Res Commun 151:608–614

    Article  CAS  PubMed  Google Scholar 

  2. De Clercq E (2009) Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. Int J Antimicrob Agents 33:307–320

    Article  CAS  PubMed  Google Scholar 

  3. Deeks SG, Overbaugh J, Phillips A, Buchbinder S (2015) HIV infection. Nat Rev Dis Primers 1:15035

    Article  PubMed  Google Scholar 

  4. Dolomanov OV, Bourhis LJ, Gildea RJ, Howard JAK, Puschmann H (2009) OLEX2: a complete structure solution, refinement and analysis program. J Appl Cryst 42:339–341

    Article  CAS  Google Scholar 

  5. Jeong LS, Choi YN, Tosh DK, Choi WJ, Kim HO, Choi J (2008a) Design and synthesis of novel 2′,3′-dideoxy-4′-selenonucleosides as potential antiviral agents. Bioorg Med Chem 16:9891–9897

    Article  CAS  PubMed  Google Scholar 

  6. Jeong LS, Tosh DK, Kim HO, Wang T, Hou X, Yun HS, Kwon Y, Lee SK, Choi J, Zhao LX (2008b) First synthesis of 4′-Selenonucleosides showing unusual southern conformation. Org Lett 10:209–212

    Article  CAS  PubMed  Google Scholar 

  7. Lin TS, Luo MZ, Liu MC, Pai SB, Dutschman GE, Cheng YC (1994) Antiviral activity of 2′,3′-dideoxy-β-L-5-fluorocytidine (β-L-FddC) and 2′,3′-dideoxy-β-L-cytidine (β-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro. Biochem Pharmacol 47:171–174

    CAS  PubMed  Google Scholar 

  8. Mathé C, Gosselin G (2006) L-nucleoside enantiomers as antivirals drugs: a mini-review. Antiviral Res 71:276–281

    Article  CAS  PubMed  Google Scholar 

  9. Mitsuya H, Broder S (1986) Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy virus-associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides. Proc Natl Acad Sci USA 83:1911–1915

    Article  CAS  PubMed  Google Scholar 

  10. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63

    Article  CAS  PubMed  Google Scholar 

  11. Nash K (2009) Telbivudine in the treatment of chronic hepatitis B. Adv Ther. 26:155–169

    Article  CAS  PubMed  Google Scholar 

  12. Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P, Desmyter J, De Clercq E (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods 20:309–321

    Article  CAS  PubMed  Google Scholar 

  13. Qu S, Kim G, Yu J, Sahu PK, Choi Y, Naik SD, Jeong LS (2016) Synthesis and anti-HIV activity of 5′-homo-2′, 3′-dideoxy-2′, 3′-didehydro-4′-selenonucleosides (5′-Homo-4′-Se-d4Ns). Asian J Org Chem 5:735–741

    Article  CAS  Google Scholar 

  14. Sahu PK, Kim G, Yu J, Ahn J, Song J, Choi Y, Jin X, Kim J, Lee SK, Park S, Jeong LS (2014) Selenoselective synthesis of 4′-selenonucleosides via seleno-Michael reaction as potent antiviral agents. Org Lett 16:5796–5799

    Article  CAS  PubMed  Google Scholar 

  15. Sahu PK, Naik S, Yu J, Jeong LS (2015) 4′-Selenonucleosides as next-generation nucleosides. Eur J Org Chem 28:6115–6124

    Article  CAS  Google Scholar 

  16. Sheldrick GM (2015a) SHELXT—Integrated space-group and crystalstructure determination. Acta Cryst A71:3–8

    Google Scholar 

  17. Sheldrick GM (2015b) Crystal structure refinement with SHELXL. Acta Cryst C71:3–8

    Google Scholar 

  18. Singh S, Gajulapati V, Kim M, Goo JI, Lee JK, Lee K, Lee CK, Jeong LS, Choi Y (2016) A divergent approach for the synthesis of D-and L-4′-ethynyl dioxolane nucleosides with potent anti-HIV activity. Synthesis 48:3050–3056

    Article  CAS  Google Scholar 

  19. Sluis-Cremer N, Arion D, Parniak MA (2000) Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs). Cell Mol Life Sci 57:1408–1422

    Article  CAS  PubMed  Google Scholar 

  20. Wrona IE, Gozman A, Taldone T, Chiosis G, Panek JS (2010) Synthesis of reblastatin, autolytimycin, and non-benzoquinone analogues: potent inhibitors of heat shock protein 90. J Org Chem 75:2820–2835

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references


This research was supported by grants from Mid-career Research Program (2016R1A2B3010164) and Basic Science Research Program (2018R1D1A1A02085459) of the National Research Foundation (NRF), Korea. Antiviral assay by C.-K. Lee (KRICT) is greatly appreciated.

Author information



Corresponding author

Correspondence to Lak Shin Jeong.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yu, J., Kim, G., Jarhad, D.B. et al. Synthesis and anti-HIV activity of l-2′,3′-Dideoxy-4′-selenonucleosides (l-4′-Se-ddNs). Arch. Pharm. Res. 42, 780–789 (2019).

Download citation


  • Antiviral
  • l-2′,3′-Dideoxy-4′-selenonucleosides
  • l-Nucleoside
  • Pummerer-type condensation
  • l-4′-Se-ddC